<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33640717</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>03</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>05</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1872-8421</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>353</Volume>
            <PubDate>
              <Year>2021</Year>
              <Month>Apr</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neuroimmunology</Title>
          <ISOAbbreviation>J Neuroimmunol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature.</ArticleTitle>
        <Pagination>
          <StartPage>577523</StartPage>
          <MedlinePgn>577523</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jneuroim.2021.577523</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0165-5728(21)00050-3</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">To report a unique case and literature review of post COVID-19 associated transverse myelitis and dysautonomia with abnormal MRI and CSF findings.</AbstractText>
          <AbstractText Label="BACKGROUND">Coronavirus disease have been reported to be associated with several neurological manifestations such as stroke, Guillain-Barré syndrome, meningoencephalitis amongst others. There are only few reported cases of transverse myelitis with the novel coronavirus (n-CoV-2) and only one reported case identifying dysautonomia in COVID-19 patient. Here, we identify a COVID-19 patient diagnosed with acute transverse myelitis in addition to dysautonomia following with complete resolution of symptoms.</AbstractText>
          <AbstractText Label="METHOD">A retrospective chart review of a patient diagnosed with post SARS-CoV-2 infection acute transverse myelitis and dysautonomia, and a review of literature of all the reported cases of transverse myelitis and COVID-19, from December 1st, 2019 till December 25th, 2020, was performed.</AbstractText>
          <AbstractText Label="CONCLUSION">To our knowledge, this is the first reported case of transverse myelitis and dysautonomia in a patient with SARS-CoV-2 infection, who responded to intravenous methyl prednisone and bromocriptine. Follow-up imaging of the spine showed complete resolution of the lesion. Further studies would be recommended to identify the underlying correlation between COVID-19 and transverse myelitis.</AbstractText>
          <CopyrightInformation>Copyright © 2021 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Moreno-Escobar</LastName>
            <ForeName>Maria Camila</ForeName>
            <Initials>MC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, West Virginia University School of Medicine, Morgantown, WV, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kataria</LastName>
            <ForeName>Saurabh</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, University of Missouri Healthcare, Columbia, MO, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khan</LastName>
            <ForeName>Erum</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>B.J. Medical College and Civil hospital, Ahmedabad, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Subedi</LastName>
            <ForeName>Roshan</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Medicine, Kathmandu, Nepal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tandon</LastName>
            <ForeName>Medha</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Safdarjung Hospital, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peshwe</LastName>
            <ForeName>Krithika</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, West Virginia University School of Medicine, Morgantown, WV, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kramer</LastName>
            <ForeName>Joshua</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, West Virginia University School of Medicine, Morgantown, WV, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Niaze</LastName>
            <ForeName>Faraze</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, West Virginia University School of Medicine, Morgantown, WV, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sriwastava</LastName>
            <ForeName>Shitiz</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, West Virginia University School of Medicine, Morgantown, WV, USA; West Virginia Clinical Transitional Science, Morgantown, WV, USA. Electronic address: shitiz.sriwastava@hsc.wvu.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Neuroimmunol</MedlineTA>
        <NlmUniqueID>8109498</NlmUniqueID>
        <ISSNLinking>0165-5728</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018491">Dopamine Agonists</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>3A64E3G5ZO</RegistryNumber>
          <NameOfSubstance UI="D001971">Bromocriptine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>X4W7ZR7023</RegistryNumber>
          <NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>J Neuroimmunol. 2021 Jun 15;355:577566</RefSource>
          <PMID Version="1">33845283</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001971" MajorTopicYN="N">Bromocriptine</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018491" MajorTopicYN="N">Dopamine Agonists</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008775" MajorTopicYN="N">Methylprednisolone</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009188" MajorTopicYN="N">Myelitis, Transverse</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
          <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054969" MajorTopicYN="N">Primary Dysautonomias</DescriptorName>
          <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Autoimmune disorder</Keyword>
        <Keyword MajorTopicYN="Y">COVID-19</Keyword>
        <Keyword MajorTopicYN="Y">Coronavirus disease 2019</Keyword>
        <Keyword MajorTopicYN="Y">Dysautonomia</Keyword>
        <Keyword MajorTopicYN="Y">MRI spine</Keyword>
        <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
        <Keyword MajorTopicYN="Y">Transverse myelitis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>28</Day>
          <Hour>20</Hour>
          <Minute>34</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33640717</ArticleId>
        <ArticleId IdType="pmc">PMC7895682</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jneuroim.2021.577523</ArticleId>
        <ArticleId IdType="pii">S0165-5728(21)00050-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Abdelhady M., Elsotouhy A., Vattoth S., Vattoth S.  2020. Acute Flaccid Myelitis in COVID-19. (2055–7159 (Electronic))</Citation>
        </Reference>
        <Reference>
          <Citation>AlKetbi R., AlNuaimi D., AlMulla M., AlTalai N., Samir M., Kumar N. Acute myelitis as a neurological complication of Covid-19: a case report and MRI findings. Radiol. Case Rep. 2020;15(9):1591–1595.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7275163</ArticleId>
            <ArticleId IdType="pubmed">32685076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baig A.A.-O.X., Khaleeq A., Ali U., Syeda H.  2020. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. (1948–7193 (Electronic))</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7094171</ArticleId>
            <ArticleId IdType="pubmed">32167747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berger J.R. COVID-19 and the nervous system. J. Neuro-Oncol. 2020;1</Citation>
        </Reference>
        <Reference>
          <Citation>Bohmwald K., Gálvez N.M.S., Ríos M., Kalergis A.M.  2020. Neurologic Alterations Due to Respiratory Virus Infections. (1662–5102 (Print))</Citation>
        </Reference>
        <Reference>
          <Citation>Borchers A.T., Gershwin M.E.  2020. Transverse Myelitis. (1873–0183 (Electronic))</Citation>
        </Reference>
        <Reference>
          <Citation>Chakraborty U., Chandra A.A.-O., Ray A.K., Biswas P.  2020. COVID-19-Associated Acute Transverse Myelitis: a Rare Entity. (LID - 10.1136/bcr-2020-238668 [doi] LID - e238668. (1757-790X (Electronic)))</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7449353</ArticleId>
            <ArticleId IdType="pubmed">32843475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chow C.A.-O., Magnussen J., Ip J., Su Y.A.-O.  2020. Acute Transverse Myelitis in COVID-19 Infection. (LID - 10.1136/bcr-2020-236720 [doi] LID - e236720. (1757-790X (Electronic)))</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7418849</ArticleId>
            <ArticleId IdType="pubmed">32784242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chowdhary A., Subedi R., Tandon M., Wen S., Patel J., Kataria S. Relevance and clinical significance of magnetic resonance imaging of neurological manifestations in COVID-19: a systematic review of case reports and case series. Brain Sci. 2020;10(12):1017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7766893</ArticleId>
            <ArticleId IdType="pubmed">33371260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Durrani M., Kucharski K., Smith Z., Fien S.  2020. Acute Transverse Myelitis Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Case Report. (2474-252X (Electronic))</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7434243</ArticleId>
            <ArticleId IdType="pubmed">32926682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eshak N., Abdelnabi M., Ball S., Elgwairi E., Creed K., Test V.  2020. Dysautonomia: An Overlooked Neurological Manifestation in a Critically ill COVID-19 Patient. (1538–2990 (Electronic))</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7366085</ArticleId>
            <ArticleId IdType="pubmed">32739039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7159299</ArticleId>
            <ArticleId IdType="pubmed">31986264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joshi U.A.-O., Subedi R., Gajurel B.P.  2020. Hepatitis B Virus Induced Cytoplasmic Antineutrophil Cytoplasmic Antibody-Mediated Vasculitis Causing Subarachnoid Hemorrhage, Acute Transverse Myelitis, and Nephropathy: a Case Report. (1752–1947 (Electronic))</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5376690</ArticleId>
            <ArticleId IdType="pubmed">28366165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kataria S., Tandon M., Melnic V., Sriwastava S.  2020. A Case Series and Literature Review of Multiple Sclerosis and COVID-19: Clinical Characteristics, Outcomes and a Brief Review of Immunotherapies. (2405–6502 (Electronic)) (Epub 2020 Nov 2. PMID: 33163634; PMCID: PMC7605741)</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ensci.2020.100287</ArticleId>
            <ArticleId IdType="pmc">PMC7605741</ArticleId>
            <ArticleId IdType="pubmed">33163634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim H.J., Paul F., Lana-Peixoto M.A., Tenembaum S., Asgari N., Palace J.  2020. MRI Characteristics of Neuromyelitis Optica Spectrum Disorder: an International Update. (1526-632X (Electronic))</Citation>
        </Reference>
        <Reference>
          <Citation>Kincaid O., Lipton H.L.  2020. Viral Myelitis: an Update. (1528–4042 (Print))</Citation>
        </Reference>
        <Reference>
          <Citation>Lycklama G., Thompson A., Filippi M., Filippi M., Miller D., Miller D., Polman C., Polman C., Fazekas F., Fazekas F., Barkhof F.  2020. Spinal-cord MRI in Multiple Sclerosis. (1474–4422 (Print))</Citation>
        </Reference>
        <Reference>
          <Citation>Mao L., Wang M., Chen S. Neurological manifestations of hospitalised patients with COVID-19 in Wuhan, China: a retrospective case series study. JAMA Neurol. 2020;77(6):683–690.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7149362</ArticleId>
            <ArticleId IdType="pubmed">32275288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Metlay J.P., Waterer G.W., Long A.C., Anzueto A., Brozek J., Crothers K. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am. J. Respir. Crit. Care Med. 2019;200(7):e45–e67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6812437</ArticleId>
            <ArticleId IdType="pubmed">31573350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munhoz R.P., Pedroso J.L., Nascimento F.A., SMD Almeida, OGP Barsottini, FEC Cardoso. Neurological complications in patients with SARS-CoV-2 infection: a systematic review. Arq. Neuropsiquiatr. 2020;78(5):290–300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32490966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munz M., Wessendorf S., Koretsis G., Tewald F., Baegi R., Krämer S.  2020. Acute Transverse Myelitis after COVID-19 Pneumonia. (1432–1459 (Electronic))</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7250275</ArticleId>
            <ArticleId IdType="pubmed">32458198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poyiadji N., Shahin G., Noujaim D., Stone M., Patel S., Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020;201187</Citation>
        </Reference>
        <Reference>
          <Citation>Proposed Diagnostic Criteria and Nosology of Acute Transverse Myelitis. 2002.  (0028–3878 (Print))</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12236201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sarma D., Bilello L.A.  2020. A Case Report of Acute Transverse Myelitis Following Novel Coronavirus Infection. (2474-252X (Electronic))</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7434287</ArticleId>
            <ArticleId IdType="pubmed">32926676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheidl E., Canseco D.D., Hadji-Naumov A., Bereznai B. Guillain-Barre syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature. J. Peripher. Nerv. Syst. 2020;25(2):204–207. doi: 10.1111/jns.12382. (Epub 2020 May 26. PMID: 32388880; PMCID: PMC7273104)</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jns.12382</ArticleId>
            <ArticleId IdType="pmc">PMC7273104</ArticleId>
            <ArticleId IdType="pubmed">32388880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sriwastava S., Tandon M., Kataria S., Daimee M., Sultan S. New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review. J. Neurol. 2020:1–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7549728</ArticleId>
            <ArticleId IdType="pubmed">33047223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sriwastava S., Kataria S., Tandon M., Patel J., Patel R., Jowkar A.  2021. Guillain Barré Syndrome and Its Variants as a Manifestation of COVID-19: A Systematic Review of Case Reports and Case Series. (1878–5883 (Electronic))</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7725056</ArticleId>
            <ArticleId IdType="pubmed">33321326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valiuddin H., Skwirsk B., Paz-Arabo P.  2020. Acute Transverse Myelitis Associated with SARS-CoV-2: A Case-Report. (2666–3546 (Electronic))</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7275168</ArticleId>
            <ArticleId IdType="pubmed">32835294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zachariadis A., Tulbu A., Strambo D., Dumoulin A., Di Virgilio G.A.-O.  2020. Transverse Myelitis Related to COVID-19 Infection. (1432–1459 (Electronic))</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7322383</ArticleId>
            <ArticleId IdType="pubmed">32601756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang T., Rodricks M.B., Hirsh E. COVID-19-associated acute disseminated encephalomyelitis: a case report. medRxiv. 2020 doi: 10.1007/s12028-020-01119-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12028-020-01119-7</ArticleId>
            <ArticleId IdType="pmc">PMC7537964</ArticleId>
            <ArticleId IdType="pubmed">33025544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao K., Huang J., Feng Y., Liu L., Nie S.  2020. Acute Myelitis after SARS-CoV-2 Infection: A Case Report.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
